Lisinopril hctz combination therapy
Pro Research Analysisby 
Searched over 200M research papers
Lisinopril HCTZ Combination Therapy: Efficacy and Blood Pressure Control
Multiple studies have shown that combining lisinopril, an ACE inhibitor, with hydrochlorothiazide (HCTZ), a thiazide diuretic, provides greater blood pressure (BP) reduction than using either drug alone. In both short-term and long-term studies, the lisinopril/HCTZ combination consistently led to larger decreases in both systolic and diastolic BP compared to monotherapy with either component, and a higher percentage of patients achieved target BP levels with the combination therapy 1367+1 MORE. This effect was observed in both general adult and elderly hypertensive populations 610.
Comparison with Other Antihypertensive Combinations
When compared to captopril/HCTZ, the lisinopril/HCTZ combination generally resulted in a greater reduction in diastolic BP and a higher proportion of patients reaching BP normalization, although differences in systolic BP reduction were not always significant 245. At trough (24 hours post-dose), lisinopril/HCTZ showed superior BP lowering compared to captopril/HCTZ . Both combinations were similarly well tolerated, with no significant differences in adverse events 245.
Metabolic Effects and Safety Profile
The lisinopril/HCTZ combination was generally well tolerated, with most side effects being mild and resolving on their own 6710. Some metabolic changes were noted: the combination increased uric acid levels more than lisinopril alone and decreased potassium less than HCTZ alone 610. Lisinopril/HCTZ also had a smaller effect on lowering potassium compared to HCTZ monotherapy . The incidence of cough was higher with lisinopril/HCTZ than with some other combinations, such as candesartan/HCTZ .
Persistence and Adherence with Single-Pill Combination
Patients prescribed a single-pill combination of lisinopril/HCTZ were more likely to continue their therapy over a year compared to those taking the two drugs as separate pills. This simplification of the regimen led to significantly higher persistence rates, which is important for long-term BP control and reducing cardiovascular risk .
Comparison with Other Drug Combinations
Lisinopril/HCTZ was found to have similar antihypertensive efficacy to candesartan/HCTZ, but candesartan/HCTZ was better tolerated, with fewer patients reporting adverse events and a lower incidence of cough .
Conclusion
Lisinopril/HCTZ combination therapy is more effective at lowering blood pressure than either drug alone and is generally well tolerated. It compares favorably to other ACE inhibitor/diuretic combinations and offers the added benefit of improved patient adherence when given as a single-pill regimen. While some metabolic changes and side effects can occur, these are typically mild. Overall, lisinopril/HCTZ is a strong option for managing mild to moderate hypertension, especially in patients who require more than one medication to achieve BP control.
Sources and full results
Most relevant research papers on this topic